Atrial Fibrillation (Prevention of Stroke) Clinical Trials in Esbjerg, Region Syddanmark

Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion